These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9593949)

  • 1. Effects of the NMDA antagonist CP-98,113 on regional cerebral edema and cardiovascular, cognitive, and neurobehavioral function following experimental brain injury in the rat.
    Okiyama K; Smith DH; White WF; McIntosh TK
    Brain Res; 1998 May; 792(2):291-8. PubMed ID: 9593949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the novel NMDA antagonists CP-98,113, CP-101,581 and CP-101,606 on cognitive function and regional cerebral edema following experimental brain injury in the rat.
    Okiyama K; Smith DH; White WF; Richter K; McIntosh TK
    J Neurotrauma; 1997 Apr; 14(4):211-22. PubMed ID: 9151770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The maxi-K channel opener BMS-204352 attenuates regional cerebral edema and neurologic motor impairment after experimental brain injury.
    Cheney JA; Weisser JD; Bareyre FM; Laurer HL; Saatman KE; Raghupathi R; Gribkoff V; Starrett JE; McIntosh TK
    J Cereb Blood Flow Metab; 2001 Apr; 21(4):396-403. PubMed ID: 11323525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat.
    McIntosh TK; Smith DH; Voddi M; Perri BR; Stutzmann JM
    J Neurotrauma; 1996 Dec; 13(12):767-80. PubMed ID: 9002062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of the anticonvulsant topiramate on neurobehavioral and histological outcomes following traumatic brain injury in rats.
    Hoover RC; Motta M; Davis J; Saatman KE; Fujimoto ST; Thompson HJ; Stover JF; Dichter MA; Twyman R; White HS; McIntosh TK
    J Neurotrauma; 2004 May; 21(5):501-12. PubMed ID: 15165359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury.
    Keck CA; Thompson HJ; Pitkänen A; LeBold DG; Morales DM; Plevy JB; Puri R; Zhao B; Dichter M; McIntosh TK
    Restor Neurol Neurosci; 2007; 25(2):77-90. PubMed ID: 17726266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury.
    Smith DH; Okiyama K; Thomas MJ; McIntosh TK
    J Neurosci; 1993 Dec; 13(12):5383-92. PubMed ID: 8254381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat.
    Okiyama K; Smith DH; Gennarelli TA; Simon RP; Leach M; McIntosh TK
    J Neurochem; 1995 Feb; 64(2):802-9. PubMed ID: 7830074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-1 (IGF-1) improves both neurological motor and cognitive outcome following experimental brain injury.
    Saatman KE; Contreras PC; Smith DH; Raghupathi R; McDermott KL; Fernandez SC; Sanderson KL; Voddi M; McIntosh TK
    Exp Neurol; 1997 Oct; 147(2):418-27. PubMed ID: 9344566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats.
    Kline AE; Yu J; Horváth E; Marion DW; Dixon CE
    Neuroscience; 2001; 106(3):547-55. PubMed ID: 11591455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor administration after traumatic brain injury in the rat does not protect against behavioral or histological deficits.
    Blaha GR; Raghupathi R; Saatman KE; McIntosh TK
    Neuroscience; 2000; 99(3):483-93. PubMed ID: 11029540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of brain edema, blood-brain barrier breakdown, and injury volume by ifenprodil, a polyamine-site N-methyl-D-aspartate receptor antagonist, after experimental traumatic brain injury in rats.
    Dempsey RJ; Başkaya MK; Doğan A
    Neurosurgery; 2000 Aug; 47(2):399-404; discussion 404-6. PubMed ID: 10942013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
    Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
    J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in rats.
    Furukawa T; Hoshino S; Kobayashi S; Asakura T; Takahashi M; Atsumi T; Teramoto A
    J Neurotrauma; 2003 Mar; 20(3):269-78. PubMed ID: 12820681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact.
    Kline AE; Massucci JL; Marion DW; Dixon CE
    J Neurotrauma; 2002 Apr; 19(4):415-25. PubMed ID: 11990348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental traumatic brain injury.
    Sinson G; Perri BR; Trojanowski JQ; Flamm ES; McIntosh TK
    J Neurosurg; 1997 Mar; 86(3):511-8. PubMed ID: 9046309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remacemide hydrochloride reduces cortical lesion volume following brain trauma in the rat.
    Smith DH; Perri BR; Raghupathi R; Saatman KE; McIntosh TK
    Neurosci Lett; 1997 Aug; 231(3):135-8. PubMed ID: 9300640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of monoclonal antibodies neutralizing the inflammatory mediators tumor necrosis factor alpha and interleukin -6 does not attenuate acute behavioral deficits following experimental traumatic brain injury in the rat.
    Marklund N; Keck C; Hoover R; Soltesz K; Millard M; LeBold D; Spangler Z; Banning A; Benson J; McIntosh TK
    Restor Neurol Neurosci; 2005; 23(1):31-42. PubMed ID: 15846030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed administration of basic fibroblast growth factor (bFGF) attenuates cognitive dysfunction following parasagittal fluid percussion brain injury in the rat.
    McDermott KL; Raghupathi R; Fernandez SC; Saatman KE; Protter AA; Finklestein SP; Sinson G; Smith DH; McIntosh TK
    J Neurotrauma; 1997 Apr; 14(4):191-200. PubMed ID: 9151768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel calcium channel blocker, (S)-emopamil, on regional cerebral edema and neurobehavioral function after experimental brain injury.
    Okiyama K; Smith DH; Thomas MJ; McIntosh TK
    J Neurosurg; 1992 Oct; 77(4):607-15. PubMed ID: 1527621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.